Global Liver Institute
Liver Cancers Council
GLOBAL LIVER INSTITUTE
Liver Cancers Council Overview
Liver Cancer News
Resources
Membership
Liver Cancers Council
With more than 60 members, GLI’s Liver Cancers Council brings together committed stakeholders across the liver cancer community to improve the liver cancer experience. The council is made up of advocacy partners, healthcare professionals, patients, survivors, partners and advocates.
Our Goals
Increase the number of liver cancer patients diagnosed at an early stage
Support knowledge, choice, and access to appropriate treatment options
Reduce disparities in diagnosis and treatment access
Advance policy and advocacy to support research, access and information for those impacted by liver cancer
Collaborations
#OctoberIs4Livers
Launched in 2018, #OctoberIs4Livers is the first and only global campaign dedicated to public awareness, policy, education, and clinical practice needs to prevent and manage liver cancer. Designed to span the globe to improve health outcomes for liver cancer patients, the #OctoberIs4Livers campaign aims to rally stakeholders in creative and impactful ways to support the countless individuals who have heard the terrifying words “you have liver cancer.”
Liver Central
GLI, in partnership with TriSalus Life Sciences, launched Liver Central, a comprehensive site for all things liver cancer. This site provides patients, clinicians, and researchers a unique hub to find information on ongoing clinical trials, treatment options, and educational materials about the liver and liver cancers.
Whitepaper: Pivotal Trial Results Look to Shake Up HCC Treatment
In collaboration with MJH communications, Amit Mahipal and Dr. Richard Kim, MD, we published a paper addressing the recent clinical breakthroughs in treatment options for patients with advanced hepatocellular carcinoma in the OncLive editorial.
Whitepaper: Achieving Health Equity in Liver Cancer
In collaboration with MJH communications and Dr. Lewis Roberts of Mayo Clinic, we published a health equity paper showcasing the global burden of liver cancer and the actions needed to reduce the stark disparity experienced among those of lower socioeconomic status.
Whitepaper: Value of HCC Surveillance: Delphi panel perspectives
In collaboration with Dr. Amit Singal, Division of Digestive and Liver Diseases, University of Texas Southwestern, we published a paper addressing a modified Delphi method. The paper examines critical topics, including the benefits and harms of surveillance, emerging modalities, and a comprehensive framework for evaluating surveillance value.
NCCN Guidelines for Patients: Hepatobiliary Cancers
An essential element of patient empowerment is accessible, actionable, high-quality information. GLI is proud to work with NCCN to provide this information to support liver and bile duct cancer patients and their families in the hope that together we can make the cancer journey easier and more successful.
One Liver to Love Campaign
In collaboration with Blue Faery Liver and Eisai, GLI launched the #OneLiverToLove campaign to provide educational resources and support services to the community living with liver cancer.
Fighting Liver Cancers with Food
The battle against liver cancer is tough, & it’s important to fuel your body for the hard work that it’s doing.
Watch now to learn how to Eat for Strength, Comfort, and Energy with GLI’s Founder, Donna Cryer and celebrity chef, Chef Daniel Thomas.
National Institute of Health, National Cancer Institute: Specialized Programs of Research Excellence (SPORE)
In collaboration with Mayo Clinic and MD Anderson, GLI serves on the SPORE advisory committee, offering objective and expert guidance on coordination of the Mayo Clinic’s Hepatobiliary Cancers SPORE and MD Anderson’s Hepatocellular Carcinoma SPORE.
TRACER External Advisory Board
In collaboration with Dr. Amit Singal, Division of Digestive and Liver Diseases, University of Texas Southwestern, GLI serves as an external advisory board member for this NIH National Liver Cancer Screening Trial, ensuring appropriate patient advocacy representation.
Membership
Global Liver Institute’s Liver Cancers Council brings together representatives from not-for-profit, for-profit, government agencies, and patient representatives capable of and committed to addressing the challenges and impact of liver cancers on individuals, communities, companies, and societies around the world.
